IL180361A0 - Compositions and methods for the prevention and control of insulin-induced hypoglycemia - Google Patents

Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Info

Publication number
IL180361A0
IL180361A0 IL180361A IL18036106A IL180361A0 IL 180361 A0 IL180361 A0 IL 180361A0 IL 180361 A IL180361 A IL 180361A IL 18036106 A IL18036106 A IL 18036106A IL 180361 A0 IL180361 A0 IL 180361A0
Authority
IL
Israel
Prior art keywords
insulin
prevention
compositions
methods
control
Prior art date
Application number
IL180361A
Other languages
English (en)
Original Assignee
Diobex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diobex Inc filed Critical Diobex Inc
Publication of IL180361A0 publication Critical patent/IL180361A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL180361A 2004-06-29 2006-12-26 Compositions and methods for the prevention and control of insulin-induced hypoglycemia IL180361A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58444904P 2004-06-29 2004-06-29
PCT/US2005/022812 WO2006004696A2 (en) 2004-06-29 2005-06-27 Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Publications (1)

Publication Number Publication Date
IL180361A0 true IL180361A0 (en) 2007-06-03

Family

ID=35783298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL180361A IL180361A0 (en) 2004-06-29 2006-12-26 Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Country Status (11)

Country Link
EP (1) EP1778266A4 (ko)
JP (1) JP2008505087A (ko)
KR (1) KR20070029276A (ko)
CN (1) CN101001638A (ko)
AU (1) AU2005260025A1 (ko)
CA (1) CA2571030A1 (ko)
IL (1) IL180361A0 (ko)
MX (1) MXPA06014970A (ko)
NO (1) NO20070174L (ko)
WO (1) WO2006004696A2 (ko)
ZA (1) ZA200700708B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5894174B2 (ja) 2010-11-03 2016-03-23 アレコー リミテッド グルカゴンを含む新規組成物
CA2995392C (en) 2015-09-04 2023-08-15 Hailiang Chen Stabilized glucagon solutions
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
CN117653715A (zh) 2017-02-03 2024-03-08 范德比尔特大学 用于治疗糖尿病的系统、组合物和方法
KR20200029019A (ko) * 2017-07-14 2020-03-17 엑스에리스 파머수티클스, 인크. 선천성 고인슐린혈증을 치료하기 위한 방법
WO2019108640A1 (en) * 2017-11-28 2019-06-06 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and kits for evaluating metabolism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897551A (en) * 1971-04-05 1975-07-29 Lilly Co Eli Iodoglucagons and process for prolonging the biological activity of glucagon
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
AU2003274601A1 (en) * 2002-11-18 2004-06-15 Pfizer Products Inc. Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides
WO2004060387A1 (en) * 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Also Published As

Publication number Publication date
MXPA06014970A (es) 2007-03-07
AU2005260025A1 (en) 2006-01-12
CN101001638A (zh) 2007-07-18
WO2006004696A3 (en) 2006-10-26
EP1778266A4 (en) 2009-09-09
CA2571030A1 (en) 2006-01-12
JP2008505087A (ja) 2008-02-21
ZA200700708B (en) 2009-03-25
KR20070029276A (ko) 2007-03-13
NO20070174L (no) 2007-03-13
EP1778266A2 (en) 2007-05-02
WO2006004696A2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
EP1578437A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND REDUCING INSULIN-INDUCED HYPOGLYCEMIA
HK1216080A1 (zh) 用於治療或預防草酸鹽相關疾病的組合物和方法
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
IL182863A0 (en) Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
PT1755391E (pt) Métodos e composições para o tratamento de neuropatias
IL183709A0 (en) Compositions and methods for treating conditions of the nail unit
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
IL183986A0 (en) Pharmaceutical compounds and compositions
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
IL180361A0 (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
EP1810689A4 (en) MEANS FOR THE PREVENTION AND / OR TREATMENT OF DIABETES
PL1762219T3 (pl) Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania
PL1812797T3 (pl) Kompozycje i sposoby do leczenia chorób hiperproliferacyjnych i zapobiegania tym chorobom
EP1778261A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND DIAGNOSIS OF INSULIN RESISTANCE
PT2474528E (pt) Compostos antineoplásicos e composições farmacêuticas dos mesmos
EP1755581A4 (en) METHODS AND COMPOSITIONS FOR TREATING MYOCARDIAL CONDITIONS
EP1776956A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CALCIPENIA
HU0400960D0 (en) Composition for controlling louses and its larvae and method for controlling louses
AU2004901220A0 (en) Compositions and methods for treatment disease
EP1804818A4 (en) METHODS AND COMPOSITIONS FOR THE USE OF ANGIOGENESIS INHIBITORS IN THE PREVENTION AND / OR CONTROL OF EPILEPSY
IL164201A0 (en) Herbal compositions for the treatment of diabetes
AU2004902179A0 (en) Methods and Compositions for the Treatment of Myocardial Conditions